A detailed history of Bank Of America Corp transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 785,570 shares of PLSE stock, worth $14.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
785,570
Previous 782,584 0.38%
Holding current value
$14.4 Million
Previous $8.76 Million 57.34%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.83 - $21.83 $32,338 - $65,184
2,986 Added 0.38%
785,570 $13.8 Million
Q2 2024

Aug 14, 2024

BUY
$6.69 - $14.54 $20,284 - $44,085
3,032 Added 0.39%
782,584 $8.76 Million
Q1 2024

May 15, 2024

SELL
$7.8 - $11.02 $169,954 - $240,114
-21,789 Reduced 2.72%
779,552 $6.79 Million
Q4 2023

Feb 14, 2024

BUY
$3.85 - $12.84 $72,510 - $241,828
18,834 Added 2.41%
801,341 $9.81 Million
Q2 2023

Aug 14, 2023

BUY
$3.67 - $8.64 $35,866 - $84,438
9,773 Added 1.26%
782,507 $5.63 Million
Q1 2023

May 12, 2023

BUY
$2.48 - $3.88 $9,905 - $15,496
3,994 Added 0.52%
772,734 $2.6 Million
Q4 2022

Feb 10, 2023

SELL
$1.73 - $2.89 $965 - $1,612
-558 Reduced 0.07%
768,740 $2.13 Million
Q3 2022

Nov 14, 2022

BUY
$1.23 - $2.3 $239 - $448
195 Added 0.03%
769,298 $1.77 Million
Q2 2022

Aug 12, 2022

SELL
$1.48 - $4.28 $75,904 - $219,508
-51,287 Reduced 6.25%
769,103 $1.18 Million
Q1 2022

May 16, 2022

BUY
$4.21 - $14.79 $166,905 - $586,349
39,645 Added 5.08%
820,390 $3.99 Million
Q4 2021

Feb 08, 2022

BUY
$14.78 - $24.4 $85,546 - $141,227
5,788 Added 0.75%
780,745 $11.6 Million
Q3 2021

Nov 15, 2021

BUY
$17.25 - $26.63 $13.1 Million - $20.2 Million
758,622 Added 4644.15%
774,957 $16.7 Million
Q2 2021

Sep 13, 2021

BUY
$16.31 - $23.64 $266,423 - $386,159
16,335 New
16,335 $268,000

Others Institutions Holding PLSE

About Pulse Biosciences, Inc.


  • Ticker PLSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,125,900
  • Market Cap $679M
  • Description
  • Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...
More about PLSE
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.